Ultimovacs ASA - ESG Rating & Company Profile powered by AI
If you are employed by Ultimovacs ASA and you wish to use your Sustainability rating, please get in touch. The ESG rating for Ultimovacs ASA represents the company's reporting of the UN Sustainable Development Goals. Check the end of this page for potential risks for Ultimovacs ASA based on industry, location and size.
Ultimovacs ASA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 8.0, social score of 6.4 and governance score of 2.0.
5.5
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
602 | SkinBioTherapeutics PLC | 5.6 | High |
602 | XOMA Corp | 5.6 | High |
627 | Ultimovacs ASA | 5.5 | High |
627 | Advanced Medical Solutions Group PLC | 5.5 | High |
627 | Achieve Life Sciences Inc | 5.5 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Ultimovacs ASA have an accelerator or VC vehicle to help deliver innovation?
Does Ultimovacs ASA disclose current and historical energy intensity?
Does Ultimovacs ASA report the average age of the workforce?
Does Ultimovacs ASA reference operational or capital allocation in relation to climate change?
Does Ultimovacs ASA disclose its ethnicity pay gap?
Does Ultimovacs ASA disclose cybersecurity risks?
Does Ultimovacs ASA offer flexible work?
Does Ultimovacs ASA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Ultimovacs ASA disclose the number of employees in R&D functions?
Does Ultimovacs ASA conduct supply chain audits?
Does Ultimovacs ASA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Ultimovacs ASA conduct 360 degree staff reviews?
Does Ultimovacs ASA disclose the individual responsible for D&I?
Does Ultimovacs ASA disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Ultimovacs ASA disclose current and / or historical scope 2 emissions?
Does Ultimovacs ASA disclose water use targets?
Does Ultimovacs ASA have careers partnerships with academic institutions?
Did Ultimovacs ASA have a product recall in the last two years?
Does Ultimovacs ASA disclose incidents of discrimination?
Does Ultimovacs ASA allow for Work Councils/Collective Agreements to be formed?
Has Ultimovacs ASA issued a profit warning in the past 24 months?
Does Ultimovacs ASA disclose parental leave metrics?
Does Ultimovacs ASA disclose climate scenario or pathway analysis?
Does Ultimovacs ASA disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Ultimovacs ASA disclose the pay ratio of women to men?
Does Ultimovacs ASA support suppliers with sustainability related research and development?
Does Ultimovacs ASA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Ultimovacs ASA reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Ultimovacs ASA involved in embryonic stem cell research?
Does Ultimovacs ASA disclose GHG and Air Emissions intensity?
Does Ultimovacs ASA disclose its waste policy?
Does Ultimovacs ASA report according to TCFD requirements?
Does Ultimovacs ASA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Ultimovacs ASA disclose energy use targets?
Does Ultimovacs ASA disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Ultimovacs ASA have a policy relating to cyber security?
Have a different question?
Potential Risks for Ultimovacs ASA
These potential risks are based on the size, segment and geographies of the company.
Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.